Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease.
Xu J, Song W, Xu Z, Danziger MM, Karavani E, Zang C, Chen X, Li Y, Paz IMR, Gohel D, Su C, Zhou Y, Hou Y, Shimoni Y, Pieper AA, Hu J, Wang F, Rosen-Zvi M, Leverenz JB, Cummings J, Cheng F.
Xu J, et al. Among authors: hu j.
Alzheimers Dement. 2024 Dec 6. doi: 10.1002/alz.14373. Online ahead of print.
Alzheimers Dement. 2024.
PMID: 39641322